Dr. Al Zahraa Mahmoud Khalifa is an emerging researcher in pharmaceutical sciences with expertise in advanced drug delivery systems, vaccine adjuvants, nano-formulations, and pharmaceutical product development. Her research focuses on the design and optimization of innovative delivery platforms including liposomes, niosomes, emulsions, and multi-modal vaccine delivery systems to improve therapeutic efficacy and patient outcomes. She has contributed significantly to the advancement of pharmaceutics through her scholarly work in formulation science, nanotechnology-based drug carriers, and subunit antigen delivery strategies. Dr. Khalifa has authored 6 research documents, accumulating 94 citations with an h-index of 4, reflecting her growing academic influence in pharmaceutical and biomedical research. Her publications appear in reputable international journals, particularly in the areas of pharmaceutics, drug delivery, and vaccine technology. With a strong commitment to translational pharmaceutical research, Dr. Al Zahraa Mahmoud Khalifa continues to contribute to the development of next-generation therapeutic and vaccine delivery technologies.